Topics and Expertise: research

Daniel Gray, PhD, is the recipient of the 2011 Julius R. and Patricia A. Krevans Distinguished Dissertation Award. The award, which honors the most outstanding doctoral dissertation by graduate department nominees who completed their PhDs at UCSF during the past year, is named for UCSF Chancellor...

Paul Ortiz de Montellano, PhD, is the newly appointed associate dean of research in the UCSF School of Pharmacy. The associate dean of research advises the UCSF School of Pharmacy dean and leaders on research trends, issues, and opportunities and represents the School's research agenda to the...

For her decades of service to the pharmacy profession, Mary Anne Koda-Kimble, PharmD, dean of the UCSF School of Pharmacy, received the highest recognition from the California State Board of Pharmacy on July 28, 2010, during a board meeting in Sacramento, California.

The launch of a new community pharmacy-based diabetes medication management pilot program for select members of the California Public Employees’ Retirement System (CalPERS) was announced by CalPERS on July 15, 2010.

Asthma specialist and genetics researcher, Esteban G. Burchard, MD, MPH, joint faculty member in the UCSF Schools of Pharmacy and Medicine, discusses the differences in the incidence of asthma and response to asthma drugs among various subgroups within the larger Latino population.

For his historic contributions to what is now known about the rate at which drugs are broken down and "cleared" from the body, Leslie Benet, PhD, was honored by the American Society for Clinical Pharmacology and Therapeutics (ASCPT) with the Oscar B. Hunter Memorial Award in Therapeutics.

A team of scientists from UCSF and colleagues have identified a new potential drug target for the herpes virus that causes Kaposi’s sarcoma. Their research reopens the possibility of using a class of drugs called protease inhibitors, against diseases ranging from cancer to Alzheimer's Disease. This...

The UCSF School of Pharmacy faculty and its UCSF faculty colleagues are being aided by the campus in their requests for funds provided to the National Institutes of Health (NIH) by the American Recovery and Reinvestment Act of 2009. The act, which was signed into law by U.S.

The wider world use of medical tests and treatments based on individual genetic differences is the focus of a new, US$5 million research program funded by the National Cancer Institute (NCI) and led by UCSF School of Pharmacy health economist Kathryn Phillips, PhD. The grant was awarded on...